NERV
Price
$1.65
Change
+$0.02 (+1.23%)
Updated
Jul 9, 12:27 PM (EDT)
Capitalization
11.4M
34 days until earnings call
TCRX
Price
$1.80
Change
+$0.10 (+5.88%)
Updated
Jul 9, 01:10 PM (EDT)
Capitalization
96.2M
35 days until earnings call
Interact to see
Advertisement

NERV vs TCRX

Header iconNERV vs TCRX Comparison
Open Charts NERV vs TCRXBanner chart's image
Minerva Neurosciences
Price$1.65
Change+$0.02 (+1.23%)
Volume$700
Capitalization11.4M
TScan Therapeutics
Price$1.80
Change+$0.10 (+5.88%)
Volume$100
Capitalization96.2M
NERV vs TCRX Comparison Chart in %
Loading...
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NERV vs. TCRX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NERV is a StrongBuy and TCRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (NERV: $1.63 vs. TCRX: $1.70)
Brand notoriety: NERV and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NERV: 61% vs. TCRX: 100%
Market capitalization -- NERV: $11.4M vs. TCRX: $96.2M
NERV [@Biotechnology] is valued at $11.4M. TCRX’s [@Biotechnology] market capitalization is $96.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NERV’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • NERV’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both NERV and TCRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NERV’s TA Score shows that 4 TA indicator(s) are bullish while TCRX’s TA Score has 7 bullish TA indicator(s).

  • NERV’s TA Score: 4 bullish, 5 bearish.
  • TCRX’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than NERV.

Price Growth

NERV (@Biotechnology) experienced а -2.40% price change this week, while TCRX (@Biotechnology) price change was +18.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.23%. For the same industry, the average monthly price growth was +16.77%, and the average quarterly price growth was +17.84%.

Reported Earning Dates

NERV is expected to report earnings on Aug 12, 2025.

TCRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+12.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCRX($96.2M) has a higher market cap than NERV($11.4M). NERV YTD gains are higher at: -26.629 vs. TCRX (-44.079). NERV has higher annual earnings (EBITDA): 8.58M vs. TCRX (-124.58M). TCRX has more cash in the bank: 252M vs. NERV (17.3M). NERV has less debt than TCRX: NERV (0) vs TCRX (97M). TCRX has higher revenues than NERV: TCRX (4.42M) vs NERV (0).
NERVTCRXNERV / TCRX
Capitalization11.4M96.2M12%
EBITDA8.58M-124.58M-7%
Gain YTD-26.629-44.07960%
P/E Ratio1.99N/A-
Revenue04.42M-
Total Cash17.3M252M7%
Total Debt097M-
FUNDAMENTALS RATINGS
NERV: Fundamental Ratings
NERV
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NERVTCRX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVPAF7.750.33
+4.45%
Ivanhoe Mines Ltd.
SEEMF0.05N/A
N/A
Seeing Machines Ltd.
USYNF0.88N/A
N/A
Unisync Corp.
TCCPY5.67-0.01
-0.18%
Technopro Holdings Inc.
EBBNF23.36-0.11
-0.47%
Enbridge Inc.